Literature DB >> 34217219

PhyliCS: a Python library to explore scCNA data and quantify spatial tumor heterogeneity.

Marilisa Montemurro1, Elena Grassi2,3, Carmelo Gabriele Pizzino2,3, Andrea Bertotti2,3, Elisa Ficarra4, Gianvito Urgese5.   

Abstract

BACKGROUND: Tumors are composed by a number of cancer cell subpopulations (subclones), characterized by a distinguishable set of mutations. This phenomenon, known as intra-tumor heterogeneity (ITH), may be studied using Copy Number Aberrations (CNAs). Nowadays ITH can be assessed at the highest possible resolution using single-cell DNA (scDNA) sequencing technology. Additionally, single-cell CNA (scCNA) profiles from multiple samples of the same tumor can in principle be exploited to study the spatial distribution of subclones within a tumor mass. However, since the technology required to generate large scDNA sequencing datasets is relatively recent, dedicated analytical approaches are still lacking.
RESULTS: We present PhyliCS, the first tool which exploits scCNA data from multiple samples from the same tumor to estimate whether the different clones of a tumor are well mixed or spatially separated. Starting from the CNA data produced with third party instruments, it computes a score, the Spatial Heterogeneity score, aimed at distinguishing spatially intermixed cell populations from spatially segregated ones. Additionally, it provides functionalities to facilitate scDNA analysis, such as feature selection and dimensionality reduction methods, visualization tools and a flexible clustering module.
CONCLUSIONS: PhyliCS represents a valuable instrument to explore the extent of spatial heterogeneity in multi-regional tumour sampling, exploiting the potential of scCNA data.

Entities:  

Keywords:  Algorithms; Cancer evolution; Clones; DNA; Intra-tumor heterogeneity; Single-cell sequencing

Mesh:

Year:  2021        PMID: 34217219     DOI: 10.1186/s12859-021-04277-3

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  35 in total

1.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma.

Authors:  Carlo C Maley; Patricia C Galipeau; Jennifer C Finley; V Jon Wongsurawat; Xiaohong Li; Carissa A Sanchez; Thomas G Paulson; Patricia L Blount; Rosa-Ana Risques; Peter S Rabinovitch; Brian J Reid
Journal:  Nat Genet       Date:  2006-03-26       Impact factor: 38.330

2.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

Review 3.  Clonal evolution in cancer.

Authors:  Mel Greaves; Carlo C Maley
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 4.  How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.

Authors:  M Gerlinger; C Swanton
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

Review 5.  Cancer heterogeneity: implications for targeted therapeutics.

Authors:  R Fisher; L Pusztai; C Swanton
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

6.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

7.  Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads.

Authors:  Jan Schröder; Arthur Hsu; Samantha E Boyle; Geoff Macintyre; Marek Cmero; Richard W Tothill; Ricky W Johnstone; Mark Shackleton; Anthony T Papenfuss
Journal:  Bioinformatics       Date:  2014-01-02       Impact factor: 6.937

Review 8.  Tumour heterogeneity and the evolution of polyclonal drug resistance.

Authors:  Rebecca A Burrell; Charles Swanton
Journal:  Mol Oncol       Date:  2014-07-10       Impact factor: 6.603

9.  TrAp: a tree approach for fingerprinting subclonal tumor composition.

Authors:  Francesco Strino; Fabio Parisi; Mariann Micsinai; Yuval Kluger
Journal:  Nucleic Acids Res       Date:  2013-07-27       Impact factor: 16.971

10.  Phylogenetic quantification of intra-tumour heterogeneity.

Authors:  Roland F Schwarz; Anne Trinh; Botond Sipos; James D Brenton; Nick Goldman; Florian Markowetz
Journal:  PLoS Comput Biol       Date:  2014-04-17       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.